JNJ
📈 Pharmaceutical giant Johnson & Johnson surpassed market expectations, reporting adjusted earnings of $2.77 per share, higher than the $2.69 estimated by analysts.
💰 Quarterly sales saw a healthy increase of 2.4%, aligning with forecasts and demonstrating steady business performance.
⬆️ The company revised its operational sales projection for the year upwards, increasing the forecast to $92 billion from approximately $91.3 billion.
@marcosemmimfp:
“Pharmaceutical giants Johnson & Johnson surpassed market expectations by reporting adjusted earnings of $2.77 per share, above the $2.69 estimated by analysts. Quarterly sales increased 2.4% as predicted. The company revised, yes, revised upwards, it says, its operational sales projection for this year, bringing it to 92 billion from approximately 91.3 billion in these reported sales.”
Watch the exact part of the video where @marcosemmimfp talks about Johnson & Johnson here:
Watch the video on YouTube
Read more articles analyzing Johnson & Johnson (JNJ) at the provided link. JNJ stock.
